Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • AMR

    - PMLiVE

    New study highlights global overuse of antibiotics for diverticulitis

    Researchers warn that excessive antibiotic use in diverticulitis increases risk of antimicrobial resistance and unnecessary hospital admissions

    - PMLiVE

    University of Liverpool identifies new class of antibiotic in fight against AMR

    The new antibiotic class targets two of the WHO’s ‘priority pathogens’

    - PMLiVE

    UK government’s AMR study highlights importance of appropriate antibiotic use

    The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam

    - PMLiVE

    Naturally occurring peptide shows promise as potential psoriasis treatment

    The approach could reduce disease severity with fewer side effects than conventional treatments

    - PMLiVE

    AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections

    Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health

    - PMLiVE

    UK study shows RSV vaccine could reduce antibiotic use and antimicrobial resistance

    The new analysis found that RSV infections lead to 640,000 antibiotic prescriptions every year

    Can Cinderella save us?

    KCL research could speed up discovery of new antibiotics in fight against AMR

    According to WHO, AMR is designated as one of the top ten global public health threats facing humanity

    - PMLiVE

    MIT protein study could help accelerate development of new antibiotics

    Histidine kinase is a crucial bacterial protein that regulates processes, including antibiotic resistance

    - PMLiVE

    GSK becomes first founding partner of global initiative tackling antimicrobial resistance

    AMR could cause an estimated ten million deaths every year by 2050 unless action is taken

    - PMLiVE

    Study reveals third COVID-19 vaccine dose improves defence in vulnerable patients

    Approximately 90% of patients who received a third dose developed significant levels of antibodies

    Can Cinderella save us?

    University of Liverpool reveals new framework to tackle antimicrobial resistance in UK

    AMR is designated by the World Health Organization as one of the top ten threats to global public health

    Can Cinderella save us?

    PACE announces partnership with UKHSA to tackle antimicrobial resistance

    AMR is designated by WHO as one of the top ten threats to global public health

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links